By Sheri Kasprzak
New York, April 25 - Sequenom, Inc. plans to close a $20 million direct placement.
The offering includes up to 6,666,666 shares at $3.00 apiece sold to new and existing institutional investors.
The shares will be sold under the company's shelf registration.
The deal is set to close April 27.
Lehman Brothers Inc. is the bookrunner for the deal with Rodman & Renshaw, LLC as co-agent.
Sequenom, based in San Diego, provides genetic analysis products used for biomedical research, livestock and agricultural applications and molecular medicine.
| Issuer: | Sequenom, Inc.
|
| Issue: | Stock
|
| Amount: | $20 million
|
| Shares: | 6,666,666
|
| Price: | $3.00
|
| Warrants: | No
|
| Placement agents: | Lehman Brothers Inc. (lead), Rodman & Renshaw, LLC
|
| Announcement date: | April 25
|
| Settlement date: | April 27
|
| Stock symbol: | Nasdaq: SQNM
|
| Stock price: | $3.25 at close April 25
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
